Novel 4'-azido-2'-deoxy-nucleoside analogs are potent inhibitors of NS5B-dependent HCV replication

被引:1
|
作者
Smiths, David
Ma, Han
Le Pogam, Sophie
Leveque, Vincent
Browns, Carl
Johansson, Nils Gunnar
Kalayanov, Genadiy
Eriksson, Staffan
Usova, Elena
Sund, Christian
Winqist, Anna
Maltseva, Tatiana
Smith, Mark
Martin, Joseph
Najera, Isabel
Klumpp, Klaus
机构
[1] Roche Palo Alto LLC, Palo Alto, CA USA
[2] Medivir AB, Huddinge, Sweden
[3] Swedish Univ Agr Sci, Biomed Ctr, Dept Mol Biosci, Uppsala, Sweden
关键词
D O I
10.1016/j.antiviral.2007.01.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
22
引用
收藏
页码:A36 / A36
页数:1
相关论文
共 50 条
  • [1] Novel 4-azido-2-deoxy-nucleoside analogs are potent inhibitors of NS5B-dependent HCV replication
    Smith, D. B.
    Ma, H.
    Le Pogam, S.
    Leveque, V.
    Brown, C.
    Johansson, N. G.
    Kalayanov, G.
    Eriksson, S.
    Usova, E.
    Sund, C.
    Winqvist, A.
    Maltseva, T.
    Smith, M.
    Jiang, W. R.
    Cammack, N.
    Martin, J. A.
    Najera, I.
    Klumpp, K.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S190 - S190
  • [2] 2′-Deoxy-nucleoside Analogs can be Potent Dual Inhibitors of HCV and HIV Replication with Selectivity against Human Polymerases
    Klumpp, Klaus
    Su, Guoping
    Leveque, Vincent
    Deval, Jerome
    Heilek, Gabrielle
    Rajyaguru, Sonal
    Li, Yu
    Hang, Julie Q.
    Ma, Han
    Inocencio, Nicole
    Kalayanov, Genadiy
    Winqvist, Anna
    Smith, David B.
    Cammack, Nick
    Johansson, Nils Gunnar
    Najera, Isabel
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A19 - A19
  • [3] 2′-DEOXY-NUCLEOSIDE ANALOGS AS POTENT DUAL INHIBITORS OF HCV AND HIV REPLICATION, WITH SELECTIVITY AGAINST OTHER VIRAL AND HUMAN POLYMERASES
    Klumpp, K.
    Su, G.
    Deval, J.
    Leveque, V.
    Jekle, A.
    Rajyaguru, S.
    Gee, P.
    Li, Y.
    Hang, J.
    Ma, H.
    Inocencio, N.
    Kalayanov, G.
    Winqvist, A.
    Smith, D.
    Cammack, N.
    Johansson, N. G.
    Heilek, G.
    Najera, I.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S346 - S346
  • [4] 2′-deoxy-4′-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2′-α-hydroxyl groups
    Klumpp, Klaus
    Kalayanov, Genadiy
    Ma, Han
    Le Pogam, Sophie
    Leveque, Vincent
    Jiang, Wen-Rong
    Inocencio, Nicole
    De Witte, Anniek
    Rajyaguru, Sonal
    Tai, Ezra
    Chanda, Sushmita
    Irwin, Michael R.
    Sund, Christian
    Winqist, Anna
    Maltseva, Tatiana
    Eriksson, Staffan
    Usova, Elena
    Smith, Mark
    Alker, Andre
    Najera, Isabel
    Cammack, Nick
    Martin, Joseph A.
    Johansson, Nils Gunnar
    Smith, David B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (04) : 2167 - 2175
  • [5] The novel nucleoside analog R1479 (4′-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture
    Klumpp, K
    Lévêque, V
    Le Pogam, S
    Ma, H
    Jiang, WR
    Kang, HS
    Granycome, C
    Singer, M
    Laxton, C
    Hang, JQ
    Sarma, K
    Smith, DB
    Heindl, D
    Hobbs, CJ
    Merrett, JH
    Symons, J
    Cammack, N
    Martin, JA
    Devos, R
    Nájera, I
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (07) : 3793 - 3799
  • [6] Cyclic phosphate prodrugs of 2′-deoxy-2¢-fluoro-2¢-C-methyl nucleoside analogs as inhibitors of HCV NS5B polymerase
    Reddy, P. Ganapati
    Bao, Donghui
    Chang, Wonsuk
    Chun, Byoung-Kwon
    Du, Jinfa
    Nagarathnam, Dhanapalan
    Rachakonda, Suguna
    Ross, Bruce S.
    Zhang, Hai-Ren
    Bansal, Shalini
    Espiritu, Christine L.
    Keilman, Meg
    Lam, Angela M.
    Niu, Congrong
    Steuer, Holly M.
    Furman, Phillip A.
    Otto, Michael J.
    Sofia, Michael J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [7] Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism
    Lougiakis, Nikolaos
    Frakolaki, Efseveia
    Karmou, Panagiota
    Pouli, Nicole
    Marakos, Panagiotis
    Madan, Vanesa
    Bartenschlager, Ralf
    Vassilaki, Niki
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (03) : 352 - 367
  • [8] Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffold
    Zhong, Min
    Peng, Eric
    Huang, Ningwu
    Huang, Qi
    Huq, Anja
    Lau, Meiyen
    Colonno, Richard
    Li, Leping
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 963 - 968
  • [9] Synthesis and evaluation of the anti-hepatitis B virus activity of 4′-Azido-thymidine analogs and 4′-Azido-2′-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent
    Onitsuka, Kengo
    Tokuda, Ryoh
    Kuwata-Higashi, Nobuyo
    Kumamoto, Hiroki
    Aoki, Manabu
    Amano, Masayuki
    Kohgo, Satoru
    Das, Debananda
    Haraguchi, Kazuhiro
    Mitsuya, Hiroaki
    Imoto, Shuhei
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2020, 39 (04): : 518 - 529
  • [10] Identification of a novel series of potent HCV NS5B Site I inhibitors
    Eastman, Kyle J.
    Yang, Zhong
    Bender, John A.
    Mosure, Kathy
    Lemm, Julie A.
    Meanwell, Nicholas A.
    Roberts, Susan B.
    Knipe, Jay
    Kadow, John F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (08) : 1993 - 1997